1-7 of 7
Joanna Gora Tybor, MD PhD
Close
Sort by
Journal Articles

A Multicenter Prospective Study on Efficacy and Safety of Ponatinib in Patients with Chronic Myeloid Leukemia Resistant or Intolerant to Previous Therapy: A 3-Year Report

Tomasz Sacha, MDPhD, Elzbieta Szczepanek, Paulina Dumnicka, PhD, Joanna Gora-Tybor, MD PhD, Joanna Niesiobedzka-Krezel, MDPhD, Witold Prejzner, MD PhD, Ewa Wasilewska, MDPhD, Janusz Kloczko, MDPhD, Hanna Ciepluch, MD, Wioletta Makowska, MD, Elzbieta Patkowska, MD, Joanna Wasilewska, MD, Grazyna Bober, MD, Malgorzata Kopera, MDPhD, Ryszard Wichary, MD, Renata Kroll-Balcerzak, MDPhD, Tomasz Gromek, MDPhD, Malgorzata Wach, MDPhD, Anna Rudkowska-Kazanowska, MD, Magdalena Swiniarska, MD, Edyta Paczkowska, MDPhD, Ewa Medras, MD, Monika Joks, MD, Marta Oller, MD, Renata Kasza, MD, Aleksandra Kostyra, MD, Justyna Gil, MD, Olga Grzybowska-Izydorczyk, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-141523
Published: 2020
Journal Articles

ASXL1 Mutations Detectable at Diagnosis May Predict Response to Imatinib in Patients with Chronic Myeloid Leukemia

Marcin M Machnicki, MSc, Monika Pepek, MSc, Iwona Solarska, PhD, Joanna Niesiobedzka-Krezel, MD PhD, Ilona Seferynska, MD PhD, Joanna Gora Tybor, MD PhD, Magdalena Zawada, PhD, Tomasz Sacha, MD PhD, Waldemar Sawicki, MD PhD, Ewa Wasilewska, MD PhD, Katarzyna Pruszczyk, MD, Malgorzata Rydzanicz, PhD, Rafal Ploski, MD PhD, Tomasz Skorski, MD PhD, Tomasz Stoklosa, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4148.
https://doi.org/10.1182/blood-2019-129834
Published: 2019
Journal Articles

Characteristics and Outcomes of Patients with Lymphoma Who Developed Therapy-Related Acute Myeloid Leukemia or Myelodysplastic Syndrome - a Retrospective Analysis of the Polish Adult Leukemia Group

Aleksandra Golos, MD PhD, Krzysztof Mądry, MD PhD, Karol Lis, Marta Sobas, MD, Agnieszka Ożańska, Magdalena Czemerska, Dorota Hawrylecka, Agnieszka Stelmach-Gołdyś, Karolina Chromik, Bartosz Pula, Ewa Lech-Maranda, MD PhD, Joanna Gora Tybor, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5422.
https://doi.org/10.1182/blood-2019-125711
Published: 2019
Journal Articles

Analysis of Predictive Factors for Early Response to Ruxolitinib in 266 Patients with Myelofibrosis from the Polish Adult Leukemia Group (PALG) Registry

Joanna Gora Tybor, MD PhD, Aleksandra Golos, MD PhD, Tomasz Sacha, MD PhD, Krzysztof Lewandowski, MD PhD, Joanna Niesiobedzka-Krezel, MD PhD, Maria Bieniaszewska, Hubert Wysoglad, Olga Grzybowska-Izydorczyk, Ilona Seferynska, MD PhD, Marta Sobas, MD, Maria Czyżewska, Agnieszka Michalska, Waldemar Sawicki, MD PhD, Malwina Mazur, Marek Hus, MD PhD, Ewa Bodzenta, Magdalena Olszewska-Szopa, Elżbieta Patkowska, Wojciech Świstek, Krzysztof Jamroziak, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4180.
https://doi.org/10.1182/blood-2019-125864
Published: 2019
Journal Articles

High Activity of Cladribine (2-CdA) Combined with Low-Dose Cytarabine in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome after Azacitidine Failure

Kamil Wisniewski, Krzysztof Madry, Sebastian Grosicki, MD PhD, Piotr Małecki, Bartosz Pula, Marzena Watek, Ewa Lech-Maranda, MD PhD, Joanna Gora Tybor, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1360.
https://doi.org/10.1182/blood-2019-123843
Published: 2019
Journal Articles

Impact of Drug Transporters ABCB1 and ABCG2 and Regulators of Xenobiotic Transport and Metabolism Pxr and CAR Gene Polymorphisms on Clinical Efficacy of Imatinib in Chronic Myeloid Leukemia (CML)

Anna Stepien, MSc, Alessandro Martino, PhD, Federico Canzian, PhD, Daniele Campa, PhD, Angelika Stein, Joanna Gora-Tybor, MD PhD, Tomasz Sacha, MD PhD, Dorota Link-Lenczowska, PhD, Izabela Florek, PhD, Witold Prejzner, MD PhD, Zofia Specht-Szwoch, Malgorzata Calbecka, MD PhD, Marcin Rymko, MD PhD, Marek Dudzinski, MD PhD, Pawel Gaj, PhD, Tadeusz Robak, MD, Krzysztof Warzocha, MD PhD, Krzysztof Jamroziak, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5222.
https://doi.org/10.1182/blood.V124.21.5222.5222
Published: 2014
Journal Articles

Real-Life Comparison Of Severe Vascular Events and Other Non-Hematological Complications In CML Patients Treated With Second Line Nilotinib Or Dasatinib

Joanna Gora-Tybor, MD, PhD, Ewa Medras, MD, PhD, Malgorzata Calbecka, MD, PhD, Agnieszka Kolkowska, MD, Edyta Ponikowska-Szyba, MD, Tadeusz Robak, MD, PhD, Krzysztof Jamroziak, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1491.
https://doi.org/10.1182/blood.V122.21.1491.1491
Published: 2013